Steminent Biotherapeutics (ROCO:7729) OCF Yield %: -2.06 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7729 Steminent Biotherapeutics Inc ROCO:7729
11 GF Score
Price NT$74.70
! 4 Warning Signs
View Full Analysis

What is Steminent Biotherapeutics OCF Yield %?

Steminent Biotherapeutics ROCO:7729 -4.70% 11 OCF Yield % is -2.06 as of Jul. 15, 2026. GuruFocus rates ROCO:7729 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 1,410 Biotechnology companies, Steminent Biotherapeutics ranks better than 69.79% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Steminent Biotherapeutics's Trailing 12-Month Cash Flow from Operations is NT$-132.31 Mil, and Market Cap is NT$5,882.27 Mil. Therefore, Steminent Biotherapeutics's OCF Yield % for today is -2.06%.

The historical rank and industry rank for Steminent Biotherapeutics's OCF Yield % or its related term are showing as below:

ROCO:7729' s OCF Yield % Range Over the Past 10 Years
Min: -10.55   Med: -6.89   Max: -2.06
Current: -2.06

During the past 6 years, the highest OCF Yield % of Steminent Biotherapeutics was -2.06%. The lowest was -10.55%. And the median was -6.89%.

ROCO:7729's OCF Yield % is ranked better than
69.79% of 1410 companies
in the Biotechnology industry
Industry Median: -8.295 vs ROCO:7729: -2.06

Steminent Biotherapeutics's OCF Margin % for the quarter that ended in Dec. 2025 was %.

Steminent Biotherapeutics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Steminent Biotherapeutics OCF Yield % Related Terms

Steminent Biotherapeutics OCF Yield % Historical Data

* Premium members only.

The historical data trend for Steminent Biotherapeutics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steminent Biotherapeutics OCF Yield % Chart

Steminent Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 -10.82 -3.30

Steminent Biotherapeutics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -10.15 -9.27 -11.79 -3.18

ROCO:7729 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Steminent Biotherapeutics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steminent Biotherapeutics OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Steminent Biotherapeutics's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Steminent Biotherapeutics's OCF Yield % falls into.


ROCO:7729
11GF Score
Steminent Biotherapeutics Inc ROCO:7729
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steminent Biotherapeutics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Steminent Biotherapeutics's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-132.312 / 4011.379710502
=-3.30%

Steminent Biotherapeutics's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-63.789 * 2 / 4011.379710502
=-3.18%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -2.06 mean?
Steminent Biotherapeutics (ROCO:7729) has a OCF Yield % of -2.06 as of Jul. 15, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Steminent Biotherapeutics and its competitors. According to the industry distribution chart, Steminent Biotherapeutics ranks #426 out of 1410 companies in the Biotechnology industry, placing it in the top 30.2%.
Is Steminent Biotherapeutics' OCF Yield % too high?
Steminent Biotherapeutics' current OCF Yield % is -2.06. Based on the distribution chart, Steminent Biotherapeutics ranks #426 out of 1410 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Steminent Biotherapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Steminent Biotherapeutics' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Steminent Biotherapeutics ranks #426 out of 1410 companies for OCF Yield %. This puts Steminent Biotherapeutics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Steminent Biotherapeutics and its competitors. Steminent Biotherapeutics's current OCF Yield % is -2.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steminent Biotherapeutics stock overvalued right now?
Steminent Biotherapeutics (ROCO:7729) has a current OCF Yield % of -2.06. The current OCF Yield % is -2.06. Steminent Biotherapeutics' overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Steminent Biotherapeutics (ROCO:7729), the current OCF Yield % is -2.06 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Steminent Biotherapeutics Business Description

Address No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445
Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.
11GF Score

Get the complete analysis for ROCO:7729

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$74.70
Price